1 minute reading time (193 words)

BDIA CSIDI CAMPAIGN WINS TWO AWARDS!

BDIA CSIDI CAMPAIGN WINS TWO AWARDS!

 

The BDIA is delighted to announce that its 2017 BDIA CSIDI (Counterfeits and Substandard Instruments and Devices Initiative) advertising campaign is the winner of the Highest Believability category and joint winner of the Highest Information Value category in the latest BDJ Readex Research.

Edmund Proffitt, Chief Executive of the BDIA, comments “We are really pleased that our CSIDI campaign is having such an impact on BDJ readers. The campaign not only conveys useful and relevant information to the profession, but serves to highlight the very real and significant dangers associated with counterfeit and non-compliant instruments and devices across the dental sector.”

Partnering with the MHRA (Medicines and Healthcare products Regulatory Agency) for the CSIDI campaign reflects the BDIA’s continued commitment to tackling the issue of unscrupulous vendors selling poor quality, substandard, counterfeit and illegal products, usually online. Highlighting the importance of making the decision to purchase from reliable, reputable suppliers to the profession means that the end-user has the assurance of high-quality products that meet all necessary requirements, and will not endanger the user or patient, nor risk action from the courts or regulatory bodies.

For further information on the BDIA or CSIDI, please visit www.bdia.org.uk

e-max.it: your social media marketing partner
In Practice Prevention – the future of skills mix?
Sparkling Resuts!

Related Posts

 

Comments

Already Registered? Login Here
No comments made yet. Be the first to submit a comment

By accepting you will be accessing a service provided by a third-party external to https://www.gdpuk.com/

GDPUK Ltd announces sale of intellectual property to leading publisher Cogora Group

cogora

GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands, events and educational platforms.

The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website. 

“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”

Tony will continue involvement in GDPUK on a consulting basis.

GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.

Please do not re-register if you have forgotten your details,
follow the links above to recover your password &/or username.
If you cannot access your email account, please contact us.

Mastodon Mastodon